(1 - 11 von 11
)
Portfolio Prof. Dr. apl. Helmut Salih - FIT
fit.uni-tuebingen.de
2014 – present: Chair (W3) for Translational Immunology, Eberhard Karls University Tübingen and Head of the Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
Making cancer stem cells visible to the immune system
www.bionity.com
"An essential mechanism of this immune resistance in leukemia stem cells is apparently the suppression of danger signals such as NKG2D-L on the cell surface," added Helmut Salih from the University Hospital of Tübingen and the German Cancer Consortium DKTK. What is behind this extraordinary protective mechanism?
Cullinan Oncology, German Cancer Research Center (DKFZ ...
investors.cullinanoncology.com
“We've long held the belief that FLT3 is among the most attractive targets in AML,” stated Helmut Salih, DKFZ/DKTK Professor and physician at Tübingen ... › ...
sortiert nach Relevanz / Datum